Benevolent AI (XAMS:BAI) FCF Yield % : -103.19 (As of Jun. 06, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Benevolent AI's Trailing 12-Month Free Cash Flow is €-67.81 Mil, and Market Cap is €65.70 Mil. Therefore, Benevolent AI's FCF Yield % for today is -103.19%.

The historical rank and industry rank for Benevolent AI's FCF Yield % or its related term are showing as below:

XAMS:BAI' s FCF Yield % Range Over the Past 10 Years
Min: -165.2 Med: -42.65 Max: -4.04
Current: -103.19

During the past 6 years, the highest FCF Yield % of Benevolent AI was -4.04%. The lowest was -165.20%. And the median was -42.65%.

XAMS:BAI's FCF Yield % is ranked worse than
86.22% of 1553 companies
in the Biotechnology industry
Industry Median: -14.28 vs XAMS:BAI: -103.19

Benevolent AI's FCF Margin % for the quarter that ended in Dec. 2023 was -587.17%.

Benevolent AI FCF Yield % Historical Data

The historical data trend for Benevolent AI's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI FCF Yield % Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-21.37

-50.29

Benevolent AI Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial				-	-10.38	-19.34	-66.60	-20.63

Competitive Comparison of Benevolent AI's FCF Yield %

For the Biotechnology subindustry, Benevolent AI's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Benevolent AI's FCF Yield % falls into.

Benevolent AI FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Benevolent AI's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-67.59	/	134.3952
	=	-50.29%

Benevolent AI's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-13.863	*	2	/	134.3952
	=	-20.63%

Benevolent AI FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Benevolent AI FCF Yield % Related Terms

Thank you for viewing the detailed overview of Benevolent AI's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (XAMS:BAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

BAIVF:USA 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI (XAMS:BAI) Headlines

No Headlines